Evidence map›Paper›PMID 24900005›Full record

ArticleNuclear medicine and molecular imaging2011

Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using (18)F-FDG PET/CT and (99m)Tc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.

Hyo Jung Seo, Yun Jung Choi, Hyun Jeong Kim, Yong Hyu Jeong, Arthur Cho, Jae Hoon Lee, Mijin Yun, Hye Jin Choi, Jong Doo Lee, Won Jun Kang

Open access · bronzeAbstract read
In one paragraph

Article in Nuclear medicine and molecular imaging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hyo Jung SeoDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Yun Jung ChoiDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Hyun Jeong KimDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Yong Hyu JeongDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Arthur ChoDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Jae Hoon LeeDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Mijin YunDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Hye Jin ChoiDivision of Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Jong Doo LeeDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Won Jun KangDivision of Nuclear Medicine, Department of Radiology, Yonsei University College of Medicine, Seongsanno250, Seodaemun-gu, Seoul, 120-752 Korea.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBone metastasis from hepatocellular carcinoma (HCC) can present with soft tissue formation, resulting in oncologic emergency. Contrast-enhanced FDG PET/CT and bone scintigraphy were compared to evaluate characteristics of bone metastases with or without soft tissue formation from HCC.

methodsOf 4,151 patients with HCC, 263 patients had bone metastases. Eighty-five patients with bone metastasis from HCC underwent contrast-enhanced FDG PET/CT. Fifty-four of the enrolled subjects had recent (99m)Tc-HDP bone scintigraphy available for comparison. Metastatic bone lesions were identified with visual inspection on FDG PET/CT, and maximum standardized uptake value (SUVmax) was used for the quantitative analysis. Confirmation of bone metastasis was based on histopathology, combined imaging modalities, or serial follow-up studies.

resultsForty-seven patients (55%) presented with soft tissue formation, while the remaining 38 patients presented without soft tissue formation. Frequent sites of bone metastases from HCC were the spine (39%), pelvis (19%), and rib cage (14%). The soft-tissue-formation group had more frequent bone pain (77 vs. 37%, p < 0.0001), higher SUVmax (6.02 vs. 3.52, p < 0.007), and higher incidence of photon defect in bone scintigraphy (75 vs. 0%) compared to the non-soft-tissue-formation group. FDG PET/CT had higher detection rate for bone metastasis than bone scintigraphy both in lesion-based analysis (98 vs. 53%, p = 0.0015) and in patient-based analysis (100 vs. 80%, p < 0 .001).

conclusionsBone metastasis from HCC showed a high incidence of soft tissue formation requiring emergency treatment. Although the characteristic findings for soft tissue formation such as photon defect in bone scintigraphy are helpful in detection, overall detectability of bone metastasis is higher in FDG PET/CT. Contrast-enhanced PET/CT will be useful in finding and delineating soft-tissue-forming bone metastasis from HCC.

Indexed as

Bone metastasisFluorodeoxyglucoseHepatocellular carcinomaPositron emission tomographySoft tissue formation

Identifiers

PMID24900005
PMCPMC4043010
OpenAlexW1972573489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.